Literature DB >> 15216937

Bioinformatics of proteases in the MEROPS database.

Alan J Barrett1.   

Abstract

Proteolytic enzymes represent approximately approximately 2% of the total number of proteins present in all types of organisms. Many of these enzymes are of medical importance, and those that are of potential interest as drug targets can be divided into the endogenous enzymes encoded in the human genome, and the exogenous proteases encoded in the genomes of disease-causing organisms. There are also naturally occurring inhibitors of proteases, some of which have pharmaceutical relevance. The MEROPS database provides a rich source of information on proteases and their inhibitors. Storage and retrieval of this information is facilitated by the use of a hierarchical classification system (which was pioneered by the compilers of the database) in which homologous proteases and their inhibitors are divided into clans and families.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15216937

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  14 in total

Review 1.  Functional genes and proteins of Clonorchis sinensis.

Authors:  Tae Im Kim; Byoung-Kuk Na; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

2.  The N-terminal ectodomain of Ninjurin1 liberated by MMP9 has chemotactic activity.

Authors:  Bum Ju Ahn; Hoang Le; Min Wook Shin; Sung-Jin Bae; Eun Ji Lee; Hee-Jun Wee; Jong Ho Cha; Ji-Hyeon Park; Hye Shin Lee; Hyo-Jong Lee; Hyunsook Jung; Zee-Yong Park; Sang Ho Park; Byung Woo Han; Ji Hae Seo; Eng H Lo; Kyu-Won Kim
Journal:  Biochem Biophys Res Commun       Date:  2012-11-07       Impact factor: 3.575

Review 3.  The proprotein convertases are potential targets in the treatment of dyslipidemia.

Authors:  Nabil G Seidah; Annik Prat
Journal:  J Mol Med (Berl)       Date:  2007-03-10       Impact factor: 4.599

4.  Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics.

Authors:  Anna Prudova; Ulrich auf dem Keller; Georgina S Butler; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2010-03-20       Impact factor: 5.911

5.  Broad coverage identification of multiple proteolytic cleavage site sequences in complex high molecular weight proteins using quantitative proteomics as a complement to edman sequencing.

Authors:  Alain Doucet; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2010-09-28       Impact factor: 5.911

6.  Effective antiprotease-antibiotic treatment of experimental anthrax.

Authors:  Serguei G Popov; Taissia G Popova; Svetlana Hopkins; Raymond S Weinstein; Rebecca MacAfee; Karl J Fryxell; Vikas Chandhoke; Charles Bailey; Ken Alibek
Journal:  BMC Infect Dis       Date:  2005-04-08       Impact factor: 3.090

7.  Genome-wide survey of prokaryotic serine proteases: analysis of distribution and domain architectures of five serine protease families in prokaryotes.

Authors:  Lokesh P Tripathi; R Sowdhamini
Journal:  BMC Genomics       Date:  2008-11-19       Impact factor: 3.969

8.  The midgut of Aedes albopictus females expresses active trypsin-like serine peptidases.

Authors:  Leonardo Saboia-Vahia; Patricia Cuervo; Andre Borges-Veloso; Nathália Pinho de Souza; Constança Britto; Geovane Dias-Lopes; Jose Batista De Jesus
Journal:  Parasit Vectors       Date:  2014-05-30       Impact factor: 3.876

9.  How to kill the honey bee larva: genomic potential and virulence mechanisms of Paenibacillus larvae.

Authors:  Marvin Djukic; Elzbieta Brzuszkiewicz; Anne Fünfhaus; Jörn Voss; Kathleen Gollnow; Lena Poppinga; Heiko Liesegang; Eva Garcia-Gonzalez; Elke Genersch; Rolf Daniel
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Crystal structure of a peptidyl-dipeptidase K-26-DCP from Actinomycete in complex with its natural inhibitor.

Authors:  Geoffrey Masuyer; Gyles E Cozier; Glenna J Kramer; Brian O Bachmann; K Ravi Acharya
Journal:  FEBS J       Date:  2016-11-06       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.